$94.97 0.00 (0%)
3/26/2009 4:00 PM

Genentech, Inc. (DNA.DL)

CAPS Rating: No stars

The Company is a biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for unmet medical needs.

Recs

0
Member Avatar bclan13 (99.42) Submitted: 12/2/2008 8:45:39 AM : Outperform Start Price: $73.18 DNA.DL Score: +9.68

Genentech/Roche have a leading understanding of angiogenesis aand are consolidating anti-angiogenesis IP / molecules. It is worth it to Roche to make this deal - I own both.

Report this Post 0 Comments

Featured Broker Partners